South Korea · Delayed Price · Currency is KRW TegoScience Statistics
Total Valuation
TegoScience has a market cap or net worth of KRW 65.33 billion. The enterprise value is 33.75 billion.
| Market Cap | 65.33B |
| Enterprise Value | 33.75B |
Important Dates
The last earnings date was Thursday, May 28, 2026.
| Earnings Date | May 28, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
TegoScience has 8.01 million shares outstanding. The number of shares has decreased by -0.06% in one year.
| Current Share Class | 8.01M |
| Shares Outstanding | 8.01M |
| Shares Change (YoY) | -0.06% |
| Shares Change (QoQ) | +0.15% |
| Owned by Insiders (%) | 42.45% |
| Owned by Institutions (%) | 0.17% |
| Float | 4.60M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 11.21 |
| PB Ratio | 1.35 |
| P/TBV Ratio | 1.39 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -4.04 |
| EV / Sales | 5.79 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -5.86 |
Financial Position
The company has a current ratio of 27.39, with a Debt / Equity ratio of 0.34.
| Current Ratio | 27.39 |
| Quick Ratio | 25.26 |
| Debt / Equity | 0.34 |
| Debt / EBITDA | n/a |
| Debt / FCF | -2.88 |
| Interest Coverage | -3.07 |
Financial Efficiency
Return on equity (ROE) is -17.17% and return on invested capital (ROIC) is -33.70%.
| Return on Equity (ROE) | -17.17% |
| Return on Assets (ROA) | -5.32% |
| Return on Invested Capital (ROIC) | -33.70% |
| Return on Capital Employed (ROCE) | -7.40% |
| Weighted Average Cost of Capital (WACC) | 7.50% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | 42 |
| Asset Turnover | 0.09 |
| Inventory Turnover | 0.94 |
Taxes
| Income Tax | -1.16B |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -58.15% in the last 52 weeks. The beta is 0.55, so TegoScience's price volatility has been lower than the market average.
| Beta (5Y) | 0.55 |
| 52-Week Price Change | -58.15% |
| 50-Day Moving Average | 11,946.60 |
| 200-Day Moving Average | 14,983.90 |
| Relative Strength Index (RSI) | 26.25 |
| Average Volume (20 Days) | 33,130 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, TegoScience had revenue of KRW 5.83 billion and -8.36 billion in losses. Loss per share was -1,044.34.
| Revenue | 5.83B |
| Gross Profit | 3.87B |
| Operating Income | -5.40B |
| Pretax Income | -9.54B |
| Net Income | -8.36B |
| EBITDA | -4.85B |
| EBIT | -5.40B |
| Loss Per Share | -1,044.34 |
Balance Sheet
The company has 48.10 billion in cash and 16.58 billion in debt, with a net cash position of 31.51 billion or 3,936.09 per share.
| Cash & Cash Equivalents | 48.10B |
| Total Debt | 16.58B |
| Net Cash | 31.51B |
| Net Cash Per Share | 3,936.09 |
| Equity (Book Value) | 48.43B |
| Book Value Per Share | 6,048.78 |
| Working Capital | 53.06B |
Cash Flow
In the last 12 months, operating cash flow was -5.71 billion and capital expenditures -52.87 million, giving a free cash flow of -5.76 billion.
| Operating Cash Flow | -5.71B |
| Capital Expenditures | -52.87M |
| Depreciation & Amortization | 551.95M |
| Net Borrowing | 26.67B |
| Free Cash Flow | -5.76B |
| FCF Per Share | -719.84 |
Margins
Gross margin is 66.45%, with operating and profit margins of -92.73% and -143.46%.
| Gross Margin | 66.45% |
| Operating Margin | -92.73% |
| Pretax Margin | -163.66% |
| Profit Margin | -143.46% |
| EBITDA Margin | -83.25% |
| EBIT Margin | -92.73% |
| FCF Margin | n/a |
Dividends & Yields
TegoScience does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 0.06% |
| Shareholder Yield | 0.06% |
| Earnings Yield | -12.79% |
| FCF Yield | -8.82% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on July 11, 2018. It was a forward split with a ratio of 2.
| Last Split Date | Jul 11, 2018 |
| Split Type | Forward |
| Split Ratio | 2 |
Scores
TegoScience has an Altman Z-Score of 3.63 and a Piotroski F-Score of 2.
| Altman Z-Score | 3.63 |
| Piotroski F-Score | 2 |